$0.2300
Last update: Feb 10, 9:30 AM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Paradigm Biopharma Stock Short Interest Report | OTC:PBIGF | Benzinga
Short interest in Paradigm Biopharmaceuticals Ltd (OTC:PBIGF) increased during the last reporting period, rising from 24.69K to 41.59K. This put -% of the company's publicly available shares short.
Based on the recent average volume of 7.18K shares traded per day, it would take 5.79 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
41.59K
Short Interest %
–
Days to Cover
5.79
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PBIGF | Paradigm Biopharmaceuticals Lt | 01/30/2026 | 02/10/2026 | — | — | 41,589 | 7,180 | 5.79 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 01/15/2026 | 01/27/2026 | — | — | 24,689 | 6,429 | 3.84 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 12/31/2025 | 01/12/2026 | — | — | 14,204 | 860 | 16.52 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 12/15/2025 | 12/24/2025 | — | — | 14,204 | 3,500 | 4.06 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 11/28/2025 | 12/09/2025 | — | — | 25,204 | 4,444 | 5.67 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 11/14/2025 | 11/25/2025 | — | — | 17,704 | 93,512 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 10/31/2025 | 11/11/2025 | — | — | 68,600 | 53,989 | 1.27 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 09/30/2025 | 10/09/2025 | — | — | 254 | 1,682 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 09/15/2025 | 09/24/2025 | — | — | 254 | 1,440 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 08/29/2025 | 09/10/2025 | — | — | 254 | 1,450 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 08/15/2025 | 08/26/2025 | — | — | 254 | — | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 07/31/2025 | 08/11/2025 | — | — | 254 | 3,000 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 07/15/2025 | 07/24/2025 | — | — | 254 | 4,170 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 06/30/2025 | 07/10/2025 | — | — | 4 | 4,000 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 06/13/2025 | 06/25/2025 | — | — | 4 | — | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 05/30/2025 | 06/10/2025 | — | — | 11,508 | 300 | 38.36 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 05/15/2025 | 05/27/2025 | — | — | 11,508 | 36 | 319.67 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 04/30/2025 | 05/09/2025 | — | — | 11,508 | — | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 04/15/2025 | 04/25/2025 | — | — | 11,508 | 3,545 | 3.25 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 03/31/2025 | 04/09/2025 | — | — | 8 | 1 | 8 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 03/14/2025 | 03/25/2025 | — | — | 1,976 | 16,000 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 02/28/2025 | 03/11/2025 | — | — | 2,020 | 222 | 9.1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 02/14/2025 | 02/26/2025 | — | — | 1,020 | 10,480 | 1 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 01/31/2025 | 02/11/2025 | — | — | 17,142 | 3,341 | 5.13 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 01/15/2025 | 01/27/2025 | — | — | 3,417 | 722 | 4.73 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 12/31/2024 | 01/10/2025 | — | — | 372 | 23 | 16.17 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 12/13/2024 | 12/24/2024 | — | — | 372 | — | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 11/29/2024 | 12/10/2024 | — | — | 372 | 1 | 372 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 11/15/2024 | 11/26/2024 | — | — | 197,313 | — | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 10/31/2024 | 11/11/2024 | — | — | 197,309 | 5,090 | 38.76 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 10/15/2024 | 10/24/2024 | — | — | 213,336 | 813 | 262.41 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 09/30/2024 | 10/09/2024 | — | — | 198,351 | 2,730 | 72.66 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 09/13/2024 | 09/24/2024 | — | — | 198,351 | 2,222 | 89.27 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 08/30/2024 | 09/11/2024 | — | — | 198,351 | 18 | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 07/31/2024 | 08/09/2024 | — | — | 212,351 | 2,333 | 91.02 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 07/15/2024 | 07/24/2024 | — | — | 218,351 | 4,000 | 54.59 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 06/28/2024 | 07/10/2024 | — | — | 199,936 | 1,127 | 177.41 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 06/14/2024 | 06/26/2024 | — | — | 225,896 | 6,757 | 33.43 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 05/31/2024 | 06/11/2024 | — | — | 198,336 | 4,545 | 43.64 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 05/15/2024 | 05/24/2024 | — | — | 198,336 | 1,055 | 188 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 04/30/2024 | 05/09/2024 | — | — | 198,336 | 234 | 847.59 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 04/15/2024 | 04/24/2024 | — | — | 198,336 | 15,000 | 13.22 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 03/28/2024 | 04/09/2024 | — | — | 199,386 | 11 | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 03/15/2024 | 03/26/2024 | — | — | 199,588 | 1 | 999.99 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 02/29/2024 | 03/11/2024 | — | — | 202,834 | 222 | 913.67 | Get Alert |
| PBIGF | Paradigm Biopharmaceuticals Lt | 02/15/2024 | 02/27/2024 | — | — | 201,834 | 564 | 357.86 | Get Alert |
Looking for the most shorted stocks?
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved